ahlam1399
06-22-2015, 05:51 PM
Kite Pharma, Bluebird collaborate on cancer T-cell therapies
(Reuters) - Cancer drug developers Kite Pharma Inc and Bluebird Bio Inc said they would partner to develop and market T-cell therapies for HPV-associated cancers.http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/47752518/sc/14/mf.gif?resize=1%2C1
http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=v-68sWvljv4:uThlms99E9w:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=v-68sWvljv4:uThlms99E9w:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=v-68sWvljv4:uThlms99E9w:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=v-68sWvljv4:uThlms99E9w:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=v-68sWvljv4:uThlms99E9w:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/v-68sWvljv4
(Reuters) - Cancer drug developers Kite Pharma Inc and Bluebird Bio Inc said they would partner to develop and market T-cell therapies for HPV-associated cancers.http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/47752518/sc/14/mf.gif?resize=1%2C1
http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=v-68sWvljv4:uThlms99E9w:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=v-68sWvljv4:uThlms99E9w:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=v-68sWvljv4:uThlms99E9w:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=v-68sWvljv4:uThlms99E9w:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=v-68sWvljv4:uThlms99E9w:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/v-68sWvljv4